Xiao-Xing Liu Selected Research

Leukemia

7/2017

An unusual intragenic promoter of PIWIL2 contributes to aberrant activation of oncogenic PL2L60.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Xing Liu Research Topics

Disease

5	Neoplasms (Cancer) 12/2021 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021 - 01/2021
1	Mental Disorders (Mental Disorder) 09/2023
1	Splenic Neoplasms (Cancer, Splenic) 01/2019
1	Carcinogenesis 07/2017
1	Leukemia 07/2017
1	Adenocarcinoma 01/2017

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 01/2017
1	Competitive Endogenous RNAIBA 12/2021
1	Long Noncoding RNAIBA 12/2021
1	NucleotidesIBA 07/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2017
1	CateninsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	TCF Transcription FactorsIBA 01/2017

Therapy/Procedure

2	Radiotherapy 01/2019 - 01/2018